A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients
暂无分享,去创建一个
E. Vasile | V. Catalano | A. Russo | B. Vincenzi | G. Tonini | G. Bronte | F. Graziano | D. Santini | G. Masi | A. Falcone | V. Virzí
[1] D. Cunningham,et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. , 2010, The New England journal of medicine.
[2] Myung Ah Lee,et al. Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial , 2010, Cancer Chemotherapy and Pharmacology.
[3] P. Garg,et al. A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer , 2010, Cancer Chemotherapy and Pharmacology.
[4] O. Kuss,et al. Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials , 2009, British Journal of Cancer.
[5] M. Highley,et al. Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study , 2009, British Journal of Cancer.
[6] I. Yasuda,et al. Multicenter phase II study of gemcitabine (GEM) plus S-1 in patients (pts) with advanced biliary tract cancer (BTC). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Y. Bang,et al. Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation , 2009, Journal of gastroenterology and hepatology.
[8] Yun Yen,et al. A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer , 2009, Cancer Chemotherapy and Pharmacology.
[9] Y. S. Kim,et al. A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer , 2009, Cancer Chemotherapy and Pharmacology.
[10] W. Scheithauer,et al. Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study , 2008, British Journal of Cancer.
[11] D. Germano,et al. Chemotherapy with Gemcitabine and Oxaliplatin in Patients with Advanced Biliary Tract Cancer: A Single-Institution Experience , 2008, Oncology.
[12] A. Zhu,et al. Systemic therapy for biliary tract cancers. , 2008, The oncologist.
[13] C. Earle,et al. Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and Gallbladder Cancer , 2008, Digestive Diseases and Sciences.
[14] J. Furuse,et al. S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study , 2008, Cancer Chemotherapy and Pharmacology.
[15] J. Trojan,et al. Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial , 2008, British Journal of Cancer.
[16] G. Pond,et al. Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer , 2007, Cancer.
[17] S. Choi,et al. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer , 2007, Cancer Chemotherapy and Pharmacology.
[18] R. Schmid,et al. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials , 2007, British Journal of Cancer.
[19] P. Philip,et al. Phase II study of erlotinib in patients with advanced biliary cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] P. Julka,et al. A phase II study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma. , 2006, Hepatobiliary & pancreatic diseases international : HBPD INT.
[21] H. Kindler. Front-line therapy of advanced pancreatic cancer. , 2005, Seminars in oncology.
[22] D. Smith,et al. Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer , 2005, British Journal of Cancer.
[23] G. Pond,et al. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] E. Van Cutsem,et al. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial. , 2005, European journal of cancer.
[25] S. Mani,et al. A Phase II Trial of Fixed Dose Rate Gemcitabine in Patients With Advanced Biliary Tree Carcinoma , 2004, American journal of clinical oncology.
[26] Manal M. Hassan,et al. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma , 2004, Cancer.
[27] W. Scheithauer,et al. Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] K. Ridwelski,et al. Outpatient Therapy with Gemcitabine and Docetaxel for Gallbladder, Biliary, and Cholangio-Carcinomas , 2002, Investigational New Drugs.
[29] M. Ducreux,et al. Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[30] J. Rudi. Chemotherapy with gemcitabine in patients with gall-bladder carcinoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[31] G. Colucci,et al. Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] L. Orlandi,et al. A phase II study of gemcitabine in gallbladder carcinoma. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[33] P. Therasse. Measuring the clinical response. What does it mean? , 2001, European journal of cancer.
[34] W. Scheithauer,et al. Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[35] G. Gores,et al. Biliary tract cancers. , 1999, The New England journal of medicine.
[36] J. Grem,et al. Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] H. Ishitsuka,et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. , 1998, European journal of cancer.
[38] D. V. Von Hoff,et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] T. Linné,et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[40] S. Mineishi,et al. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] H. Kantarjian,et al. Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia. , 1990, Cancer research.
[42] Y Z Xu,et al. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine. , 1990, Molecular pharmacology.
[43] Y. Maehara,et al. Phase II trial of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) chemotherapy in patients with advanced biliary tree cancers. , 2010, Japanese journal of clinical oncology.
[44] B. Vincenzi,et al. A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[45] B. Reigner,et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients , 2000, Cancer Chemotherapy and Pharmacology.